Current concepts of the pathogenesis of sarcoidosis suggest that the expanded numbers of activated T-helper/inducer cells at sites of disease activity result, at least in part, from their proliferation in the local milieu. Normal clonal proliferation of T cells involves-activation and expression of the IL 2 receptor (IL 2R) gene. Thus, knowing that IL 2R mRNA transcripts are relatively long lived, we hypothesized that sarcoid blood T cells may contain IL 2R mRNA transcripts and express functional surface IL 2R, although the cells are probably activated elsewhere. Northern analysis using a 32P-labeled cDNA probe for the IL 2R p55 protein demonstrated that blood T cells of patients with active sarcoidosis, but not of normal patients, express 3.5-and 1.5-kb IL 2R mRNA transcripts, the same as those observed in normal T cells activated in vitro. Consistent with this, using flow cytometry and an MAb directed against the IL 2R p55 protein (2A3), we observed detectable levels of IL 2R surface protein on increased numbers of blood T cells of active sarcoidosis patients (4.7±0.9%) compared with blood.T cells of normal patients (0.9±0.2%). Importantly, when the sarcoid blood T cells were exposed to IL 2 in vitro, they proliferated at a rate greater than that of normal blood T cells under the same conditions, suggesting that the IL 2R spontaneously expressed by sarcoid blood T cells were functionally active. In the context of the known compartmentalization of spontaneous IL 2 production and T cell proliferation at sites of disease in active pulmonary sarcoidosis, these IL 2R positive blood T cells would probably have a proliferative advantage if they trafficked to sites of active sarcoidosis, such as the lower respiratory tract.
Introduction
Sarcoidosis is a chronic granulomatous disorder characterized at sites of disease by the accumulation of activated helper/inducer T lymphocytes (1) (2) (3) (4) (5) (6) (7) (8) (9) . In this context, evaluation of inflammatory cell populations in affected organs of individuals with active sarcoidosis has demonstrated increased numbers of CD4+ (helper/inducer) T cells that express surface activation markers such as the IL 2 receptor (IL 2R)' (10, 11) , D-related-antigen (8, 11, 12) , 5/9 (13) , and very late activation antigen-I (VLA-1) ( 14) . Furthermore, these T cells at the site of disease proliferate at an exaggerated rate and release mediators typical of activated T lymphocytes,-including IL 2 (11, (15) (16) (17) , IFN-y (18, 19) , monocyte chemotactic factor (4, 13) , and a nonspecific stimulus for Ig production by B lymphocytes (13, 20) . In comparison, evaluation of the blood ofthese individuals demonstrates decreased numbers and proportions ofCD4+ T cells. Furthermore, the blood T cells do not proliferate, and do not release the mediators spontaneously released by their autologous counterparts that are compartmentalized at sites of disease (2-5, 8, 11, 13-16, 18, 20) . Consistent with these observations, lung T cells ofthese individuals spontaneously express the IL 2 gene, whereas the blood T cells do not (21) . Although sarcoidosis is a systemic disorder, in that it often involves several organs, in the context of the observation of the compartmentalization of activated T cells to the sites of disease, it thus has been concluded that the activation ofthese T lymphocytes occurs locally at the sites of disease and the activated T cells accumulate in the local milieu. Activation thus is not a generalized property of T cells throughout the bodies of patients with active sarcoidosis (2-5, 8, 11, 13-16, 18, 20, 21) .
That T cells traffic from organs to lymph node to blood and back (22) (23) (24) (25) (26) (27) (28) , together with recent observations suggesting similar T cell antigen receptor ,8-chain gene rearrangements of T cells in both blood and lung of patients with active sarcoidosis (29) , has led us to ask whether blood T cells ofsuch individuals are truly quiescent, or whether a proportion of these cells has been at least partially activated. We thus capitalized on the knowledge that, of the immune response genes expressed after activation, IL 2R mRNA transcripts are relatively long lived (30) (31) (32) (33) (43) and a 32P-labeled cDNA probe coding for the IL 2R p55-chain (specific activity of 2-5 X 0I dpm/,ug). The IL 2R cDNA probe (44) was derived from the plasmid pIL2R2, encompassing exons I through-VI and the first 20 bp ofexon VII ofthe IL 2R p55-chain cDNA (pIL2R2 was a gift of T. Waldmann, National Cancer Institute). As a control, parallel filters were hybridized with cDNA of the human y-actin gene (plasmid PHFrA-1, provided by P. Gunning and L. Kedes, Stanford University [45] ). The blood and lung T cells from patients with sarcoid and the blood T cells from normal patients were evaluated immediately after purification, with no added stimulation. As a control, T cells were cultured in RPMI 1640 medium (Biofluids, Inc., Rockville, MD) supplemented with 10% FCS (Biofluids, Inc.), 2 mM glutamine, 100 U/ml penicillin, and 100 Ag/ml streptomycin together with 5 ug/ml PHA (Burroughs-Wellcome, Research Triangle Park, NC) plus 2 ng/ml PMA (phorbol myristate acetate; Sigma Chemical Co., St. Louis, MO) for 6 h at 37'C. The relative amounts of IL 2R mRNA present in total cellular RNA of T lymphocytes from each individual were determined by densitometric comparisons ofthe autoradiograms using laser densitometry (2202 Ultrascan; LKB Instruments, Gaithersburg, MD). Results are presented in arbitrary units ranging from 0 to 100, calculated by a linear plot, with 0 representing background densitometric signal and 100 representing the densitometric signal ofa standard pool of RNA obtained from PHA-/PMA-stimulated normal peripheral blood T cells.
In the context of reports that blood monocytes can express surface IL 2R under certain conditions (46, 47) (although significantly fewer per cell than T cells), blood monocytes or lung macrophages contaminating the T cell preparations might contribute to the IL 2R mRNA observed in sarcoid. To exclude this possibility, control experiments evaluated blood monocytes (isolated by adherence for 1 h at 370C on plastic dishes; > 95% pure by morphology and nonspecific esterase staining) and alveolar macrophages (isolated by adherence for I h at 370C on plastic dishes, > 99% pure by morphology and nonspecific esterase staining) from patients with active sarcoidosis for the presence of IL 2R mRNA transcripts.
Evaluation of the expression of IL 2R on T lymphocytes. The expression of surface IL 2R by blood T cells in sarcoid patients and normals was evaluated by direct immunofluorescence using 2A3 MAb, which is specific for the p55-chain protein (48) . Ficoll-Hypaque purified blood mononuclear cells ( Evaluation ofthe capacity ofblood lymphocytes to respond to IL 2.
To evaluate the functional significance of the surface IL 2R on the sarcoid blood T cells, purified T cells from blood of patients with active pulmonary sarcoidosis and normal patients were evaluated for their ability to proliferate in vitro in the presence of exogenous IL 2. To accomplish this, the purified T cells were cultured in round-bottom microtiter wells at a concentration of 5 X 104 cells per well in RPMI 1640 medium supplemented with 10% FCS, 2 mM glutamine, 100 U/ml penicillin, and 100 ,ug/ml streptomycin with or without IL 2 (recombinant human IL 2, final concentration of 10 U/ml Cetus Corp., Emeryville, CA).
[3H]Thymidine (0.5 MCi/well, 110 Ci/mM sp act; Amersham Corp., Arlington Heights, IL) was added at the initiation of the culture. After 4, 12, 24, and 48 h at 37°C, the cells were harvested and cytocentrifuge preparations were processed for autoradiographic analysis (15) . The slides were stained with Wright-Giemsa, 
Results
Presence ofIL 2R mRNA transcripts in sarcoid blood T lymphocytes. Compared with normal blood T cells, T lymphocytes recovered from the blood of individuals with sarcoidosis contained mRNA transcripts for the IL 2 receptor (Fig. 1 was apparent that the differences observed were consistent throughout the populations evaluated (Fig. 2) . active pulmonary sarcoidosis. The IL 2 receptor is a vital component used in the process of T cell proliferation (50) ; for T cells to respond to the growth signal IL 2, they must express functional, so-called high affinity IL 2 receptors on their surface (51). It is now recognized that the IL 2 receptor system, originally thought to be composed of one protein (52) , is composed of 55-and 70-kD proteins (53) . Whereas p55-and p70-chains independently form low affinity surface receptors, the functional high affinity IL 2 receptor that responds to IL 2 is thought to be composed of one p55-chain and one p70-chain (54) . To evaluate the IL 2R in sarcoid, we have used a cDNA probe (pIL2R2) specific for the IL 2R p55-chain and a MAb (2A3) that is specific for the p55-chain protein (48) , and have ensured that the IL 2R expressed by sarcoid T cells were functional by demonstrating that these cells respond to IL 2 by proliferating at a rate greater than that of normal cells. The finding that sarcoid lung T lymphocytes express IL 2R p55 surface protein and mRNA transcripts concurs with prior evidence of local activation of these cells at a site of disease (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) 55 (30) (31) (32) (33) . In comparison, the peak ofIL 2R mRNA transcripts, at least for the gene coding for the 55-kD IL 2R p55-chain, is later, with levels peaking at 24 h and mRNA transcripts easily detectable at 48 h. In sarcoid, evaluation of IL 2 mRNA transcripts in lung and blood of patients with active pulmonary sarcoidosis has shown that lung, but not blood, T cells contain these gene transcripts (21) . Furthermore, when sarcoid lung T cells are placed in culture without stimulation, the IL 2 mRNA transcripts diminished rapidly, similar to what occurs in vitro after T cell activation (21, 30) . In the context of in vitro studies of the kinetics of IL 2 and IL 2R mRNA transcripts after in vitro T cell activation, these observations contradict the possibility that T cells in sarcoid are activated in blood. They support the concept that the T cells have been activated at the sites of disease, but have recently trafficked to the blood. These results concur with known trafficking patterns of lymphocytes activated in response to localized antigens or alloantigens, in which many lymphocytes are initially activated and trapped at the antigen site, but then leave the site of inflammation to recirculate throughout the body (24-26, 57, 58) . These migrating cells can selectively emigrate into tissues similar to where the initial stimulation occurred (57, 59) . In this context, recent studies have identified a class of ubiquinated molecules that allow blood-borne lymphocytes to recognize and bind specialized organ-specific high endothelial venules, thus directing circulating lymphocytes to migrate selectively into different organs and tissues (60) (61) (62) (63) (64) . Some of the IL 2R+ lung T cells in sarcoidosis may represent T cells originally activated in the lung (or elsewhere) that circulate and migrate to the alveolar spaces. However, the presence ofboth IL 2R mRNA and IL 2 mRNA in sarcoid lung T cells and the fact that no IL 2 mRNA is found in sarcoid blood lymphocytes, argue that at least a proportion of the lung T cells have been activated locally in the lung tissue. Interestingly, normal lung T lymphocytes express IL 2R p55 surface protein, whereas normal blood T lymphocytes express very little (10, 11, 52, 55, 65, 66) . Consistent with these reports, in this study the proportion of IL 2R+ lung lymphocytes approached the proportion of IL 2R+ sarcoid lung lymphocytes. Quantitatively, however, this finding is consistent with the concept that the total number of IL 2R+ T cells in the sarcoid lung must greatly exceed that found in the normal lung because of the increased number of total T cells in the sarcoid lung (2-16, 20, 21, 36-38, 66) . This difference between sarcoid and normal lung is even more striking when comparing the total number of IL 2R+ T cells of the CD4+ T cell subset in the sarcoid versus normal lung (1 1, 66) . Furthermore, sarcoid lung T cells produce IL 2 and proliferate at an exaggerated rate, whereas normal lung T cells do not. The stimulus of T cells in the environment of the sarcoid lung thus is both quantitatively and qualitatively different from that found in the normal lung environment. Although these IL 2R+ lung T cells in normals might represent T cells, partially activated in the local milieu, that do not traffic to the blood under ordinary conditions, an inability to obtain sufficient numbers of normal lung T cells for mRNA analysis has made this interpretation speculative. As evidence shows that IL 2R surface protein is present longer than mRNA expression (30, 50, 67) , it is also possible these normal IL 2R+ lung T cells are not activated locally, but represent recirculating T cells that have been activated elsewhere and are trapped in the alveolar spaces.
Whereas the evidence in this study directly supports the local activation-recent trafficking to blood hypothesis over the activated in blood hypothesis, the evidence also supports the third hypothesis, that a subset of T cells throughout the body have IL 2R genes that are chronically activated in a fashion perhaps analogous to that observed in some T cell lines derived from patients with human T cell lymphoblastic virus (HTLV)-1 type lymphoma (68) . Furthermore, consistent with this generalized IL 2R gene activation hypothesis, IL 2R mRNA transcripts have been detected in lung and blood T cells in sarcoid patients (55) . However, although the IL 2R gene may be generally activated throughout the body, sarcoid does not appear to be associated with HTLV-1 infection (69). Furthermore, when sarcoid blood T cells are placed in culture over a 24-h period without stimulation, the number of IL 2R mRNA transcripts diminishes, suggesting activation of the IL 2R gene is not a constitutive property of sarcoid T cells (unpublished observation).
Independent ofthe mechanism that causes sarcoid blood T cells to contain IL 2R mRNA and express surface IL 2 receptors, the fact that these receptors are functional suggests that circulating sarcoid T cells have a proliferative advantage compared with normal T cells. In this regard, if these T cells were to traffic to an IL 2-rich environment like that of the sarcoid lung, they may further augment the already ongoing localized exaggerated T cell proliferative process. Furthermore, since the sarcoid blood T lymphocytes expressing the IL 2R are those of the helper/inducer (CD4+) subclass (1 1, 66) , this would likely result in enhanced accumulation of CD4+ T cells at sites of disease, a process that is known to occur in active sarcoidosis (4, 7-9, 11-16, 21) .
